• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta 分泌酶切割 Tau 介导了阿尔茨海默病中的 Tau 病理学和传播。

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.

出版信息

Exp Mol Med. 2020 Aug;52(8):1275-1287. doi: 10.1038/s12276-020-00494-7. Epub 2020 Aug 28.

DOI:10.1038/s12276-020-00494-7
PMID:32859953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8080617/
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease with age as a major risk factor. AD is the most common dementia with abnormal structures, including extracellular senile plaques and intraneuronal neurofibrillary tangles, as key neuropathologic hallmarks. The early feature of AD pathology is degeneration of the locus coeruleus (LC), which is the main source of norepinephrine (NE) supplying various cortical and subcortical areas that are affected in AD. The spread of Tau deposits is first initiated in the LC and is transported in a stepwise manner from the entorhinal cortex to the hippocampus and then to associative regions of the neocortex as the disease progresses. Most recently, we reported that the NE metabolite DOPEGAL activates delta-secretase (AEP, asparagine endopeptidase) and triggers pathological Tau aggregation in the LC, providing molecular insight into why LC neurons are selectively vulnerable to developing early Tau pathology and degenerating later in the disease and how δ-secretase mediates the spread of Tau pathology to the rest of the brain. This review summarizes our current understanding of the crucial role of δ-secretase in driving and spreading AD pathologies by cleaving multiple critical players, including APP and Tau, supporting that blockade of δ-secretase may provide an innovative disease-modifying therapeutic strategy for treating AD.

摘要

阿尔茨海默病(AD)是一种进行性神经退行性疾病,年龄是主要的风险因素。AD 是最常见的痴呆症,其异常结构包括细胞外老年斑和神经元内神经原纤维缠结,是关键的神经病理学特征。AD 病理学的早期特征是蓝斑(LC)的退化,LC 是供应受 AD 影响的各种皮质和皮质下区域的去甲肾上腺素(NE)的主要来源。Tau 沉积物的扩散首先在 LC 中启动,并随着疾病的进展逐步从内嗅皮层传递到海马体,然后传递到新皮层的联合区域。最近,我们报道 NE 代谢物 DOPEGAL 激活 δ-分泌酶(AEP,天冬酰胺内肽酶)并引发 LC 中病理性 Tau 聚集,为 LC 神经元为何选择性易患早期 Tau 病理学并在疾病后期退化以及 δ-分泌酶如何介导 Tau 病理学向大脑其他部位扩散提供了分子见解。这篇综述总结了我们目前对 δ-分泌酶通过切割包括 APP 和 Tau 在内的多个关键分子在驱动和传播 AD 病理学中的关键作用的理解,支持抑制 δ-分泌酶可能为治疗 AD 提供一种创新的疾病修饰治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/607a0d5c3a32/12276_2020_494_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/45a09fb07c90/12276_2020_494_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/f782ddc1a8b1/12276_2020_494_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/397cc45f86f5/12276_2020_494_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/607a0d5c3a32/12276_2020_494_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/45a09fb07c90/12276_2020_494_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/f782ddc1a8b1/12276_2020_494_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/397cc45f86f5/12276_2020_494_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/8080617/607a0d5c3a32/12276_2020_494_Fig4_HTML.jpg

相似文献

1
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.Delta 分泌酶切割 Tau 介导了阿尔茨海默病中的 Tau 病理学和传播。
Exp Mol Med. 2020 Aug;52(8):1275-1287. doi: 10.1038/s12276-020-00494-7. Epub 2020 Aug 28.
2
Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.C/EBPβ/δ-分泌酶轴的时空激活调节阿尔茨海默病的发病机制。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12427-E12434. doi: 10.1073/pnas.1815915115. Epub 2018 Dec 10.
3
Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.创伤性脑损伤通过 δ-分泌酶触发 APP 和 Tau 的裂解,介导阿尔茨海默病病理。
Prog Neurobiol. 2020 Feb;185:101730. doi: 10.1016/j.pneurobio.2019.101730. Epub 2019 Nov 25.
4
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
5
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.Delta 分泌酶切割的 Tau 拮抗 TrkB 神经营养信号,介导阿尔茨海默病病理学。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9094-9102. doi: 10.1073/pnas.1901348116. Epub 2019 Apr 19.
6
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.去甲肾上腺素代谢产物 DOPEGAL 在蓝斑中激活 AEP 和病理性 Tau 聚集。
J Clin Invest. 2020 Jan 2;130(1):422-437. doi: 10.1172/JCI130513.
7
Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP/hMAPT double transgenic mice.Delta 分泌酶在野生型 hAPP/hMAPT 双转基因小鼠中引发阿尔茨海默病病理。
Cell Death Dis. 2020 Dec 12;11(12):1058. doi: 10.1038/s41419-020-03270-7.
8
Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.肠道炎症触发阿尔茨海默病中 Aβ和 Tau 纤维的 C/EBPβ/δ- 依赖性肠脑传播。
EMBO J. 2021 Sep 1;40(17):e106320. doi: 10.15252/embj.2020106320. Epub 2021 Jul 14.
9
δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.在阿尔茨海默病中,δ-分泌酶切割的Tau通过上调STAT1-BACE1信号通路刺激β-淀粉样蛋白生成。
Mol Psychiatry. 2021 Feb;26(2):586-603. doi: 10.1038/s41380-018-0286-z. Epub 2018 Oct 31.
10
Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.SRPK2介导的δ-分泌酶磷酸化增强其酶活性,引发阿尔茨海默病的发病机制。
Mol Cell. 2017 Sep 7;67(5):812-825.e5. doi: 10.1016/j.molcel.2017.07.018. Epub 2017 Aug 17.

引用本文的文献

1
miR-361-5p contributes to the pathogenesis of Alzheimer's disease.微小RNA-361-5p促成阿尔茨海默病的发病机制。
Sci Rep. 2025 Aug 23;15(1):31046. doi: 10.1038/s41598-025-17112-z.
2
Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition.针对tau片段的免疫疗法可减轻阿尔茨海默病病理,改善突触功能和认知。
Mol Neurodegener. 2025 May 27;20(1):60. doi: 10.1186/s13024-025-00854-9.
3
Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies.

本文引用的文献

1
Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays.使用新型 Elecsys Aβ(1-42)、pTau 和 tTau 脑脊液免疫分析物预测临床衰退和向阿尔茨海默病或痴呆的转化。
Sci Rep. 2019 Dec 13;9(1):19024. doi: 10.1038/s41598-019-54204-z.
2
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.去甲肾上腺素代谢产物 DOPEGAL 在蓝斑中激活 AEP 和病理性 Tau 聚集。
J Clin Invest. 2020 Jan 2;130(1):422-437. doi: 10.1172/JCI130513.
3
Initiation of Parkinson's disease from gut to brain by δ-secretase.
解读糖皮质激素调节激酶1在阿尔茨海默病中的作用:通向新型治疗策略的一条充满希望的途径。
Inflammopharmacology. 2025 May 15. doi: 10.1007/s10787-025-01777-z.
4
Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer's Disease.新型松萝酸衍生物作为阿尔茨海默病多靶点药物的合成与生物学评价
Molecules. 2025 May 2;30(9):2030. doi: 10.3390/molecules30092030.
5
Spatiotemporal Imaging of Catechol Aldehydes in Neural Tissue.神经组织中儿茶酚醛的时空成像
JACS Au. 2025 Mar 13;5(4):1717-1727. doi: 10.1021/jacsau.4c01249. eCollection 2025 Apr 28.
6
Secretase promotes AD progression: simultaneously cleave Notch and APP.分泌酶促进阿尔茨海默病进展:同时切割Notch和淀粉样前体蛋白(APP)。
Front Aging Neurosci. 2024 Nov 20;16:1445470. doi: 10.3389/fnagi.2024.1445470. eCollection 2024.
7
Cell-cell communication: new insights and clinical implications.细胞间通讯:新的见解和临床意义。
Signal Transduct Target Ther. 2024 Aug 7;9(1):196. doi: 10.1038/s41392-024-01888-z.
8
A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer's disease mouse models through attenuating mitochondrial function.在阿尔茨海默病小鼠模型中,一种tau片段通过削弱线粒体功能将类似抑郁的行为与认知衰退联系起来。
Front Aging Neurosci. 2023 Dec 6;15:1293164. doi: 10.3389/fnagi.2023.1293164. eCollection 2023.
9
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy.针对阿尔茨海默病中的tau蛋白:从机制到临床治疗
Neural Regen Res. 2024 Jul 1;19(7):1489-1498. doi: 10.4103/1673-5374.385847. Epub 2023 Sep 22.
10
Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.Tau蛋白截短在阿尔茨海默病发病机制中的作用:一篇叙述性综述
Neural Regen Res. 2024 Jun 1;19(6):1221-1232. doi: 10.4103/1673-5374.385853. Epub 2023 Sep 22.
δ-分泌酶介导帕金森病从肠道到大脑的发病过程
Cell Res. 2020 Jan;30(1):70-87. doi: 10.1038/s41422-019-0241-9. Epub 2019 Oct 24.
4
Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.BDNF/TrkB 神经营养活性缺乏通过上调阿尔茨海默病中的 C/EBPβ 刺激 δ-分泌酶。
Cell Rep. 2019 Jul 16;28(3):655-669.e5. doi: 10.1016/j.celrep.2019.06.054.
5
Asparagine endopeptidase cleaves tau at N167 after uptake into microglia.天冬酰胺内肽酶在被小胶质细胞摄取后在 N167 处切割 tau。
Neurobiol Dis. 2019 Oct;130:104518. doi: 10.1016/j.nbd.2019.104518. Epub 2019 Jun 21.
6
Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.Delta 分泌酶切割的 Tau 拮抗 TrkB 神经营养信号,介导阿尔茨海默病病理学。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9094-9102. doi: 10.1073/pnas.1901348116. Epub 2019 Apr 19.
7
Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis.在诊断不明确的记忆诊所患者中,[F]氟替美莫 PET 的临床影响。
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1276-1286. doi: 10.1007/s00259-019-04297-5. Epub 2019 Mar 26.
8
Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.C/EBPβ/δ-分泌酶轴的时空激活调节阿尔茨海默病的发病机制。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12427-E12434. doi: 10.1073/pnas.1815915115. Epub 2018 Dec 10.
9
Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.Delta 分泌酶(AEP)介导 tau 剪接失衡,并加速 tau 病的认知衰退。
J Exp Med. 2018 Dec 3;215(12):3038-3056. doi: 10.1084/jem.20180539. Epub 2018 Oct 29.
10
α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease.α-突触核蛋白刺激单胺氧化酶-B 和凝乳蛋白酶介导帕金森病的病理学。
EMBO J. 2018 Jun 15;37(12). doi: 10.15252/embj.201798878. Epub 2018 May 16.